# FDA Inspection 1178651 - Opto-Pharm Pte Ltd. - September 01, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/opto-pharm-pte-ltd/3f4fae1e-2dde-411d-aeb6-4195a22ee1c3
Source feed: FDA_Inspections

> FDA Inspection 1178651 for Opto-Pharm Pte Ltd. on September 01, 2022. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1178651
- Company Name: Opto-Pharm Pte Ltd.
- Inspection Date: 2022-09-01
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1078347 - 2019-01-25](https://www.globalkeysolutions.net/records/fda_inspections/opto-pharm-pte-ltd/dcbf8a1b-2154-4fde-9f03-a32f7c794d3c)
- [FDA Inspection 970156 - 2016-03-22](https://www.globalkeysolutions.net/records/fda_inspections/opto-pharm-pte-ltd/1292a456-4e83-4827-a025-7d0ced5ef888)
- [FDA Inspection 854767 - 2013-06-24](https://www.globalkeysolutions.net/records/fda_inspections/opto-pharm-pte-ltd/67cb7954-f86a-40d7-92be-5018257d40b4)

Company: https://www.globalkeysolutions.net/companies/opto-pharm-pte-ltd/770d6d56-7b53-46ea-9b0e-e18a3f26d67e

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c